Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management
Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
Phase I/II, randomized, double-blind, comparator-controlled, dose-escalation study to assess
the safety, PK, and efficacy of single postsurgical application of TLC590 compared with
Naropin®